Patient-Friendly Explanation

Weight loss medicines only work while they are taken, and many people stop early because of nausea, cost or slow results. Missing doses or stopping suddenly usually means the weight comes back. Planning for side effects and keeping follow-up appointments makes it much easier to stay on treatment.

Clinical Definition

Real-world studies consistently show low persistence with anti-obesity pharmacotherapy, with a large proportion of patients discontinuing within the first three to six months because of gastrointestinal adverse effects, cost or supply problems, injection burden, and expectations that exceed early results. Adherence and persistence correlate with greater total weight loss and greater comorbidity improvement, and structured follow-up, gradual dose titration, antiemetic strategies and clear expectation-setting all improve continuation. Abrupt cessation of incretin-based therapy is typically followed by weight regain and loss of glycaemic benefit.

Why It Matters

Adherence support is a clinical intervention, not an afterthought — follow-up scheduling matters as much as the prescription itself. NuLifeCare Singapore builds titration, side-effect management and review into every medication plan.